Jiefei Geng Selected Research

TAK-165

1/2018

Synergistic effect of a novel autophagy inhibitor and Quizartinib enhances cancer cell death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiefei Geng Research Topics

Disease

2	Neoplasms (Cancer) 01/2018 - 08/2015
2	Huntington Disease (Huntington's Disease) 03/2015 - 03/2015
2	Starvation 02/2008 - 12/2006
1	Fibrosis (Cirrhosis) 01/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2015
1	Alzheimer Disease (Alzheimer's Disease) 03/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2015

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 03/2015 - 12/2006
1	CollagenIBA 01/2023
1	TAK-165IBA 01/2018
1	quizartinibIBA 01/2018
1	Drug CombinationsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	EnzymesIBA 08/2015
1	HexokinaseIBA 08/2015
1	Glucose (Dextrose)FDA LinkGeneric 08/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2015
1	ProteomeIBA 03/2015
1	Amino Acids FDA Link 12/2006
1	NitrogenIBA 12/2006

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2018
1	Therapeutics 01/2018